Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07490522 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Remote Monitoring of Gout Feasibility Study in Primary Care

Study acronym: ReMonit Gout
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Recruitment opened
    • Site details revised
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this feasibility study is to determine the feasibility of a patient self-management app (MinUrinsyregikt) for patients with gout. The primary objectives of the study are: 1. To determine the feasibility of a patient self-management app for patients with gout receiving GP follow-up. 2. To determine the feasibility of conducting a future randomised controlled trial to test the effectiveness of the app for patients with gout in primary care. Participants will be asked to test the self-management app for 3 months. Data will be collected from the participants and their GPs.
Trial Details
NCT Number NCT07490522
Lead Sponsor Diakonhjemmet Hospital
Collaborators: The Dam Foundation, The Norwegian Rheumatism Association, Diakonhjemmet Hospital AS, REMEDY - Center for treatment of Rheumatic and Musculoskeletal Diseases
Conditions
(from sponsor)
Gout
Related terms Gout
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov